Peripheral CCK and ß-Endorphin as Potential Neuroendocrine Markers of Nocebo Effects: Evidence from a Multiple-Threat Pain Paradigm.

Köhler A, Engler H, Pawlik RJ, Ceylan A, Kleine-Borgmann J, Elsenbruch S, Aulenkamp JL

Open source

DOI
10.1159/nim/adxag011
Published
2026 Oct 12
Container
Neuroimmunomodulation
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/nim/adxag011,
  title = {Peripheral CCK and ß-Endorphin as Potential Neuroendocrine Markers of Nocebo Effects: Evidence from a Multiple-Threat Pain Paradigm.},
  author = {Köhler A and Engler H and Pawlik RJ and Ceylan A and Kleine-Borgmann J and Elsenbruch S and Aulenkamp JL},
  year = {2026},
  journal = {Neuroimmunomodulation},
  doi = {10.1159/nim/adxag011},
  url = {https://doi.org/10.1159/nim/adxag011}
}

RIS

TY  - JOUR
TI  - Peripheral CCK and ß-Endorphin as Potential Neuroendocrine Markers of Nocebo Effects: Evidence from a Multiple-Threat Pain Paradigm.
AU  - Köhler A
AU  - Engler H
AU  - Pawlik RJ
AU  - Ceylan A
AU  - Kleine-Borgmann J
AU  - Elsenbruch S
AU  - Aulenkamp JL
PY  - 2026
JO  - Neuroimmunomodulation
DO  - 10.1159/nim/adxag011
UR  - https://doi.org/10.1159/nim/adxag011
ER  - 

APA

A, K., H, E., RJ, P., A, C., J, K., S, E., & JL, A. (2026). Peripheral CCK and ß-Endorphin as Potential Neuroendocrine Markers of Nocebo Effects: Evidence from a Multiple-Threat Pain Paradigm.. Neuroimmunomodulation. https://doi.org/10.1159/nim/adxag011

Source records